Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash and cash equivalents	$ 708,529	$ 526,597
Restricted cash and cash equivalents	215,157	770,000
Marketable securities	5,336	0
Accounts receivable	1,039,835	725,827
Inventories, net	503,611	374,439
Prepaid expenses and other current assets	36,938	39,402
Income taxes receivable	51,594	0
Deferred income taxes	420,503	257,985
Assets held for sale	0	160,257
Total current assets	2,981,503	2,854,507
MARKETABLE SECURITIES	2,584	2,979
PROPERTY, PLANT AND EQUIPMENT, NET	413,886	372,077
GOODWILL	3,804,959	1,372,832
OTHER INTANGIBLES, NET	3,133,963	1,872,926
DEFERRED INCOME TAXES	752	0
OTHER ASSETS	251,902	96,535
TOTAL ASSETS	10,589,549	6,571,856
CURRENT LIABILITIES:
Accounts payable	273,909	263,241
Accrued expenses	1,836,594	983,842
Current portion of long-term debt	153,229	414,929
Income taxes payable	0	3,089
Deferred income taxes	1,024	0
Liabilities related to assets held for sale	0	31,571
Total current liabilities	2,264,756	1,696,672
DEFERRED INCOME TAXES	488,682	310,764
LONG-TERM DEBT, LESS CURRENT PORTION, NET	4,219,309	3,323,844
OTHER LIABILITIES	1,086,610	655,360
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
Euro deferred shares, $0.01 par value; 4,000,000 shares authorized; 4,000,000 issued	51	0
Ordinary shares, $0.0001 and $0.01 par value; 1,000,000,000 and 350,000,000 shares authorized; 153,669,377 and 144,413,074 shares issued; 153,669,377 and 115,354,393 shares outstanding at September 30, 2014 and December 31, 2013, respectively	15	1,444
Additional paid-in capital	3,076,343	1,166,375
(Accumulated deficit) retained earnings	(541,602)	126,234
Accumulated other comprehensive loss	(44,086)	(4,915)
Treasury stock, zero and 29,058,681 shares at September 30, 2014 and December 31, 2013, respectively	0	(763,120)
Total Endo Health Solutions Inc. stockholders’ equity	2,490,721	526,018
Noncontrolling interests	39,471	59,198
Total stockholders’ equity	2,530,192	585,216
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 10,589,549	$ 6,571,856